Abiopharma

🔍 McBee Brannin (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 40,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 13,149 shares of Class A Common Stock at $88.7021 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 26,851.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 14,765 shares of Class A Common Stock at $89.7015 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,086.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Sold 8,798 shares of Class A Common Stock at $90.5475 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,288.00 | transaction_form_type: 4 | Footnotes: F3, F6, F2
• Sold 2,876 shares of Class A Common Stock at $91.5994 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 412.00 | transaction_form_type: 4 | Footnotes: F3, F7, F2
• Sold 252 shares of Class A Common Stock at $92.49 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 160.00 | transaction_form_type: 4 | Footnotes: F3, F8, F2
• Sold 160 shares of Class A Common Stock at $93.501 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F9, F2
• Acquired 12,500 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 12,500.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 4,110 shares of Class A Common Stock at $88.7022 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,390.00 | transaction_form_type: 4 | Footnotes: F3, F4, F10
• Sold 4,612 shares of Class A Common Stock at $89.701 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,778.00 | transaction_form_type: 4 | Footnotes: F3, F5, F10
• Sold 2,750 shares of Class A Common Stock at $90.5474 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,028.00 | transaction_form_type: 4 | Footnotes: F3, F6, F10
• Sold 899 shares of Class A Common Stock at $91.5993 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 129.00 | transaction_form_type: 4 | Footnotes: F3, F7, F10
• Sold 79 shares of Class A Common Stock at $92.4901 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 50.00 | transaction_form_type: 4 | Footnotes: F3, F8, F10
• Sold 50 shares of Class A Common Stock at $93.501 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F9, F10
• Sold 164 shares of Class A Common Stock at $88.7132 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,336.00 | transaction_form_type: 4 | Footnotes: F3, F4, F11
• Sold 196 shares of Class A Common Stock at $89.7226 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,140.00 | transaction_form_type: 4 | Footnotes: F3, F5, F11
• Sold 106 shares of Class A Common Stock at $90.5405 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,034.00 | transaction_form_type: 4 | Footnotes: F3, F6, F11
• Sold 33 shares of Class A Common Stock at $91.6035 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,001.00 | transaction_form_type: 4 | Footnotes: F3, F7, F11
• Sold 1 shares of Class A Common Stock at $92.53 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 49,000.00 | transaction_form_type: 4 | Footnotes: F3, F11
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 1,800.00 | Footnotes: F12
• Sold 40,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 3,517,227.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 12,500 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: C | equity_swap_involved: 0 | shares_owned_after: 436,205.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F10
• Holds 108,600 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 108,600.00 | Footnotes: F1, F1, F1, F13
• Holds 1,582,773 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 1,582,773.00 | Footnotes: F1, F1, F1, F2
• Holds 122,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 122,000.00 | Footnotes: F1, F1, F1, F14
• Holds 263,795 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: H | shares_owned_after: 263,795.00 | Footnotes: F1, F1, F1, F10

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.
• F3: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.19 to $89.18, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.19 to $90.18, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.19 to $91.18, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.19 to $92.085, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.19 to $92.88, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.31 to $93.90, inclusive.
• F10: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.
• F11: The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
• F12: The reported securities are directly held of record by the reporting person's child.
• F13: The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.
• F14: The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
• REMARKS: This Form 4 is Part 2 of 2 for this reporting person. Transactions by the reporting person are continued on this Part 2.